Skip to main content
Peptron, Inc. logo

Peptron, Inc. — Investor Relations & Filings

Ticker · 087010 ISIN · KR7087010005 KO Manufacturing
Filings indexed 226 across all filing types
Latest filing 2024-08-16 Capital/Financing Update
Country KR South Korea
Listing KO 087010

About Peptron, Inc.

http://www.peptron.com/

Peptron, Inc. is a biotechnology company specializing in peptide engineering and the development of sustained-release (SR) medications. The company's core focus is its proprietary SmartDepot platform technology, which enables the long-acting formulation of peptide-based drugs to treat chronic and life-threatening disorders. A key area of development is in neurodegenerative diseases, with a notable pipeline candidate being a sustained-release formulation of exenatide, based on patents exclusively licensed from the NIH. Peptron operates its own GMP-compliant manufacturing facility to produce its SR formulations, supporting its progression from pre-clinical research to commercial-stage development.

Recent filings

Filing Released Lang Actions
증권신고서(지분증권) (2024.10)
Capital/Financing Update Classification · 100% confidence The document is a '증권신고서' (Securities Registration Statement) filed with the Financial Services Commission of South Korea. It details a capital increase (rights offering) for Peptron, including the number of shares, offering price, and risk factors associated with the investment. This document is a formal regulatory filing for capital raising, which falls under the 'Capital/Financing Update' category.
2024-08-16 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Peptron' (주식회사 펩트론) covering the period from January 1, 2024, to June 30, 2024. It contains detailed financial information, business operations, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2024
2024-08-14 Korean
기타시장안내 (업종변경 안내)
Regulatory Filings Classification · 100% confidence The document is a short announcement from the Korea Exchange regarding a change in the company's industry classification code due to a revision in the Korean Standard Industrial Classification. It does not fit into specific financial reporting categories like 10-K, IR, or ER, and is not a report publication announcement. Therefore, it falls under the general regulatory filing category.
2024-06-28 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Peptron' (주식회사 펩트론) covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial information, business operations, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-16 Korean
주요사항보고서(유형자산양도결정)
M&A Activity Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korea Exchange (KRX) regarding the decision to dispose of tangible assets (유형자산 양도 결정). It details the asset, the transaction amount, the counterparty, and the purpose of the sale. Since this is a specific regulatory disclosure of a material corporate event that does not fit into the other specialized categories like M&A, dividends, or financial reports, it falls under the 'Regulatory Filings' category.
2024-03-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과). It details the approval of financial statements, director appointments, and remuneration limits, which are standard components of a post-AGM voting results disclosure. This falls under the category of Declaration of Voting Results.
2024-03-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.